|
ON THE SATURATION TRANSFER EFFECTS IN PRESATURATION NMR EXPERIMENTS OF PEPTIDE AND PROTEINS
|
|
|
多肽和蛋白质NMR预饱和实验中饱和转移效应的研究 |
|
ON rDNA TRANSCRIPTIONAL ACTIVITY OF THE BONE MARROW LYMPHOCYTE IN THE MICE BEARING BY SARCOMA-180 CELL
|
|
|
带腹水癌肉瘤S-180小鼠的骨髓淋巴细胞rDNA转录活性变化的研究 |
|
OPHTHALMIC GENETICS AND MOLECULAR BIOLOGY LECTURES IN ZHONGSHAN OPHTHALMIC CENTER
|
|
|
中山眼科中心举办《眼科遗传学及分子生物学讲座》 |
|
OPSONOPHAGOCYTIC ASSAY OF MONOCLONAL ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA GROUP Ⅰ STRAIN PA10115
|
|
|
抗绿脓杆菌Ⅰ群10115株单克隆抗体的调理吞噬活性的检测 |
|
OPTIMIZED CONDITIONS FOR PROTOPLAST FORMATION AND REGENERATION OF ASPERGILLUS NIGER AND TRICHODERMA REESEI——Ⅰ. SELECTION FOR STABLIZER BUFFER SYSTEM AND ENZYME MIXTURE
|
|
|
黑曲霉与里氏木霉原生质体形成和再生条件选择 Ⅰ.缓冲稳定剂系统及酶配比 |
|
ORAL CYCLOSPORINE PHARMACOKINETICS IN RENAL TRANSPLANTATION PATIENTS
|
|
|
肾移植病人口服环孢素的药代动力学 |
|
Object Using SELDI protein chip technology to detect the different serum protein spectrum of HBV infected carriers and HCC patient ,and to explore serum markers for diagnosis of HCC.
|
|
|
目的:用SELDI蛋白质芯片技术检测HBV感染携带者与肝细胞癌(HCC)患者血清蛋白质谱的差异性表达,以发现HCC的早期诊断标志物。 |
|
Objective To analyze features of IL-2 among Th1/Th2 cytokines in serum from patients with breast cancer and with breast benign Tumour and its clinical significance .
|
|
|
目的分析乳腺良、恶性肿瘤患者血清Th1/Th2细胞因子中IL-2的特点及其意义。 |
|
Objective To analyze the relationship between drug resistance and genome DNA polymorphism by establishing the typing technology of random amplified polymorphic DNA and the drug sensitive characteristic in Candia albicans.
|
|
|
目的通过建立白色念珠菌随机扩增多态性DNA(RAPD)分型技术,结合药敏特性,分析白色念珠菌基因组DNA多态性与耐药性的关系。 |
|
Objective To compare the difference of CD34 and lineage-associated antigen expression between previously untreated adult and childhood B cell acute lymphoblastic leukemia (B-ALL).
|
|
|
目的 了解成人与儿童急性B淋巴细胞性白血病 (B -ALL)中CD34和伴系抗原表达的情况及两者是否有所不同。 |
|
Objective To construct smad3-responsive destabilized enhanced green fluorescent protein(d2EGFP) reporter system,which was employed as the high throughput screening system of antagonistic agents of scar hypertrophy.
|
|
|
目的:构建Smad3反应性不稳定增强型绿色荧光蛋白(d2EGFP)报告系统,作为抗瘢痕增生药物高通量筛选体系。 |
